Drug Name: Vabysmo
Indications: To treat neovascular (wet) aged-related macular degeneration and diabetic macular edema.
Active Ingredient: Faricimab-svoa
Company: Genentech, Inc
Approval Date: 1/28/2022
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761235s000lbl.pdf